Search for Clinical Trial Results
Limited Systemic Sclerosis - 3 Studies Found
Status | Study |
Completed |
Study Name: A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma Condition:
Date: 2013-06-05 |
Completed |
Study Name: Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet Condition: Ischemia Date: 2010-02-19 Interventions: Drug: ambrisentan Subjects will receive ambrisentan 5 mg orally once daily or identical placebo pills fo |
Withdrawn |
Study Name: Systemic Sclerosis Clinical and Biomarker Study Condition:
Date: 2015-08-20 |